Prognoses of MDS subtypes RARS, RCMD and RCMD-RS are comparable but cytogenetics separates a subgroup with inferior clinical course
Leukemia Research, 05/25/2012
Bacher U et al. – The results support to combine RCMD (refractory cytopenia with multilineage dysplasia) and RCMD–RS (ring sideroblasts) as performed by WHO and emphasize the prognostic power of cytogenetic criteria for these Myelodysplastic syndromes (MDS) subtypes.



